Cargo Therapeutics Inc (CRGX) - News Archive

Showing 3 of 3 results.

From Setbacks to Solutions: CARGO Therapeutics Navigates Strategic Challenges with Promising Tri-Specific CAR T-Cell Therapy CRG-023,

CARGO Therapeutics Advances with Innovative CRG-023 Amid Strategic Reevaluation: The Future of B-Cell Lymphoma TreatmentIn a notable development within the biotech landscape, CARGO Therapeutics has announced its decisio...

Jan 29, 2025 • Biotechnology & Pharmaceuticals Industry Management Announcement CARGO

CARGO Therapeutics Announces ASH 2024 on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct De...

Tri-Specific CAR T-Cell Therapy: A New Dawn for B-Cell Lymphoma Treatment Insights from CARGO Therapeutics Promising ASH 2024 In the rapidly evolving field of immuno-oncology, the emergence of innovative therapies conti...

Nov 5, 2024 • Biotechnology & Pharmaceuticals Industry Clinical Study biotechnology

Unveiling the Future of Cancer Treatment CARGO Therapeutics Revolutionary Firi-cel CAR T-Cell Therapy Showcases Rema...

In recent groundbreaking news, renowned biotechnology firm CARGO Therapeutics has unveiled their exceptional Firi-cel CAR T-Cell Therapy in a Phase 1 Clinical Study published in The Lancet. The study has generated signi...

Jul 10, 2024 • Biotechnology & Pharmaceuticals Industry Clinical Study biotechnology